Condition
Philadelphia-Negative ALL clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Philadelphia-Negative ALL clinical trials that are recruiting, at sites in 2 countries (most in China (1), United States (1)). By phase: Phase 2 (1), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
Treatment for Acute Lymphoblastic Leukemia using modified T cells
This study is testing a new treatment using specially modified T cells to see if it can help people with Acute Lymphoblastic Leukemia who haven't had success with other therapies.
-
Comparing Blinatumomab with hyperCVAD for treating Philadelphia-negative B-ALL
This study is testing if combining Blinatumomab with lighter chemotherapy can help young adults with a type of leukemia feel better and have fewer side effects compared to a standard treatment.
Related topics
Quick answers
How many Philadelphia-Negative ALL clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in China (1 trial), United States (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.